PHAT
Phathom Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $960.58M | Price | $13.55 |
| Volume | 1.44M | Change | +1.80% |
| P/E Ratio | -2.9 | Open | $14.43 |
| Revenue | $55.3M | Prev Close | $13.31 |
| Net Income | $-334.3M | 52W Range | $2.21 - $19.50 |
| Div Yield | N/A | Target | $21.38 |
| Overall | 55 | Value | 40 |
| Quality | 36 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyPhathom Pharmaceuticals Inc. (PHAT) is a leading Manufacturing company in the Medicinal and Botanical Manufacturing industry, currently trading at $13.55 with a market capitalization of $960.58 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows PHAT with a volume of 1.44 million shares. The stock opened up 8.41% from yesterday's close of $13.31. Current analyst estimates project earnings of $-2.7 per share for this year, with next year targeting $0.53.
PHAT demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PHAT include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 57.8%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:13 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $13.55 | +1.8% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW